Skip to main content

Market Research Outlook

MRO Tracker · Pharma

A free public sample tracking new API, starting material, peptide and CDMO plants in India, with capacity, investment, build stage and an analyst note for each project. Need a full map of a molecule or segment? Ask us for a custom study.

12projects
6states
9commissioned
14 Nov 2026last reviewed

Key starting materials · Lyfius Pharma (Aurobindo Pharma) · Kakinada SEZ

Penicillin G fermentation plant

Capacity
15,000 MT a year of Penicillin G; 1,80,000 MT of glucose
Investment
Rs 2,270.05 crore
Commissioning
Commissioned April 2024 under the bulk drugs PLI scheme
End use
Penicillin based antibiotics
Stage
Commissioned
MRO View: India's largest bet on fermentation based antibiotic inputs. The plant has created 2,353 direct jobs and logged cumulative production of Rs 1,191 crore so far.

Key starting materials · Qule Pharma (Aurobindo Pharma) · Kakinada SEZ

6 APA plant

Capacity
3,600 MT a year
Investment
Not disclosed
Commissioning
Commissioned April 2024
End use
Semi synthetic penicillins
Stage
Commissioned
MRO View: Sits next to the Penicillin G plant, so Aurobindo now makes the antibiotic chain from fermentation to intermediate in one SEZ.

APIs · Kinvan Pvt Ltd (DPB Group) · Plassara, Nalagarh

Potassium clavulanate plant

Capacity
400 MT a year
Investment
Rs 504.68 crore
Commissioning
Commissioned under the bulk drugs PLI scheme
End use
Amoxicillin clavulanate combinations
Stage
Commissioned
MRO View: India's first fermentation based clavulanate plant. Domestic demand was put at about 700 tonnes a year when the project began, so imports still fill part of the gap.

APIs · Andhra Organics (Virchow Laboratories) · Pydibhimavaram, Srikakulam

Sulfadiazine, Telmisartan and Olmesartan API plant

Capacity
Not disclosed
Investment
Rs 151.47 crore
Commissioning
Commissioned under the bulk drugs PLI scheme
End use
Anti infective and cardiovascular medicines
Stage
Commissioned
MRO View: Adds domestic supply of two widely used blood pressure APIs and creates 221 direct jobs.

Key starting materials · Meghmani LLP · Dahej

Para amino phenol plant

Capacity
13,500 MT a year
Investment
Rs 60.46 crore
Commissioning
Commissioned under the bulk drugs PLI scheme
End use
Paracetamol
Stage
Commissioned
MRO View: Built for about Rs 60 crore, the plant has already logged cumulative production of Rs 687 crore of the main paracetamol starting material, which was earlier largely imported.

APIs · Centrient Pharmaceuticals India · Nawanshahr

Atorvastatin API plant

Capacity
206 MT a year
Investment
Rs 161.13 crore
Commissioning
Commissioned under the bulk drugs PLI scheme
End use
Cholesterol lowering medicines
Stage
Commissioned
MRO View: Cumulative production has reached Rs 432 crore, ahead of the plant's capital cost.

APIs · Divi's Laboratories · Ontimamidi, Kakinada

Unit III greenfield plant, Phase 1

Capacity
Not disclosed
Investment
Not disclosed
Commissioning
Commercial operations from 1 Jan 2025
End use
Key starting materials and intermediates for its API and custom synthesis business
Stage
Commissioned
MRO View: Divi's is using Unit III for pre chemistry work to free GMP space at its older units, and plans to qualify it for regulated manufacturing over time.

Peptides and CDMO · Neuland Laboratories · Bonthapally

Commercial peptide plant, Module 1

Capacity
7,000 L reactor capacity (750 L solid phase, 6,250 L liquid phase)
Investment
USD 30 million
Commissioning
Operations began September 2026
End use
Peptide APIs for innovator and biotech clients, including GLP 1 programmes
Stage
Commissioned
MRO View: The first of four modules. Module 2 is planned at up to 18,000 L and will be sized to an anchor customer's needs.

Peptides and CDMO · Laurus Bio (Laurus Labs) · Visakhapatnam

Commercial fermentation plant, Phase 1

Capacity
More than 400 kL
Investment
USD 40 million for Phase 1 construction
Commissioning
Operational by end 2026 (company)
End use
Microbial fermentation for CDMO clients
Stage
Under construction
MRO View: A step into large scale biomanufacturing for a company best known for chemistry. It sits alongside new ADC and gene therapy capacity Laurus is building in Hyderabad.

Peptides and CDMO · Laurus Labs · IP Rambilli Phase II, Anakapalli

Laurus Pharma Zone campus

Capacity
Not disclosed; 531.77 acres allotted
Investment
More than USD 600 million over eight years (company)
Commissioning
Capex to begin toward the end of FY27
End use
APIs, CDMO and formulations
Stage
Approved
MRO View: One of the largest single pharma land allotments in Andhra Pradesh. Spending starts late FY27, so output is a FY29 or later story.

Excipients · Sudeep Pharma · Nandesari

Greenfield excipients and specialty ingredients plant

Capacity
51,200 MT a year
Investment
Not disclosed
Commissioning
State FDA approval to begin manufacturing disclosed 26 Oct 2026; supplies from H2 FY27
End use
Pharma excipients and food and nutrition ingredients
Stage
Approved
MRO View: About 60% of capacity is earmarked for the company's existing pharma and nutrition portfolio, which lowers ramp up risk once customer qualification is done.

APIs · Aarti Pharmalabs · Tarapur Unit 5

Additional xanthine derivatives block

Capacity
Not disclosed
Investment
Not disclosed
Commissioning
Inaugurated June 2026; trial production started
End use
Caffeine and other xanthine derivatives
Stage
Commissioned
MRO View: The company says the block places it among the top three xanthine derivative makers globally, with ramp up planned over the next few quarters.

All 12 projects at a glance

CompanyProjectStateCapacityStage
Lyfius Pharma (Aurobindo Pharma)Penicillin G fermentation plantAndhra Pradesh15,000 MT a year of Penicillin G; 1,80,000 MT of glucoseCommissioned
Qule Pharma (Aurobindo Pharma)6 APA plantAndhra Pradesh3,600 MT a yearCommissioned
Kinvan Pvt Ltd (DPB Group)Potassium clavulanate plantHimachal Pradesh400 MT a yearCommissioned
Andhra Organics (Virchow Laboratories)Sulfadiazine, Telmisartan and Olmesartan API plantAndhra PradeshNot disclosedCommissioned
Meghmani LLPPara amino phenol plantGujarat13,500 MT a yearCommissioned
Centrient Pharmaceuticals IndiaAtorvastatin API plantPunjab206 MT a yearCommissioned
Divi's LaboratoriesUnit III greenfield plant, Phase 1Andhra PradeshNot disclosedCommissioned
Neuland LaboratoriesCommercial peptide plant, Module 1Telangana7,000 L reactor capacity (750 L solid phase, 6,250 L liquid phase)Commissioned
Laurus Bio (Laurus Labs)Commercial fermentation plant, Phase 1Andhra PradeshMore than 400 kLUnder construction
Laurus LabsLaurus Pharma Zone campusAndhra PradeshNot disclosed; 531.77 acres allottedApproved
Sudeep PharmaGreenfield excipients and specialty ingredients plantGujarat51,200 MT a yearApproved
Aarti PharmalabsAdditional xanthine derivatives blockMaharashtraNot disclosedCommissioned

Need the numbers behind this tracker?

We map API capacity, import dependence and plant pipelines for pharma clients.

Get the monthly India tracker updateNew state data and new plant announcements in one short email, once a month.

One email a month. Reply to any email to unsubscribe. Privacy policy